Partners
International Collaboration
The nanoLyme project is made possible through the collaboration of these renowned academic institutions and research centers.
Unizar
The public University of the Autonomous Community of Aragon.
Role:
Unizar coordinates the project and participates in all activities, leveraging its expertise in ICP-MS in clinical analysis, single-cell analysis, and the development of Artificial Intelligence models.
URL:
https://www.unizar.es/-
Dr. Martín Resano Ezcaray
(i3A, Departamento de Química Analítica)
-
Dra. Esperanza García Ruiz
(i3A, Departamento de Química Analítica)
-
Dra. Maite Aramendía Marzo
(i3A, Departamento de Química Analítica)
-
Dr. Eduardo Bolea Fernández
(i3A, Departamento de Química Analítica)
-
Dr. Flávio Venancio Nakadi
(i3A, Departamento de Química Analítica)
-
Dra. Maite Bona García
(OPE Unizar)
IIS
The Health Research Institute of the Hospital Complex formed by the Teaching and University Hospitals 'Hospital Clínico Universitario Lozano Blesa' and 'Hospital Universitario Miguel Servet' and Primary Health Care.
Role:
IIS Aragón will collaborate in all actions, being especially important in communication with patient associations, obtaining real samples, and evaluating and validating the effectiveness of the developed diagnostic methods, as well as in dissemination actions.
URL:
http://www.iisaragon.es-
Dr. Luis Rello Varas
(Sección Bioquímica Clínica, Hospital Universitario Miguel Servet)
-
Dña. Elena García González
(Sección Bioquímica Clínica, Hospital Universitario Miguel Servet)
-
Lourdes Villarroya Lahuerta
(OPE IIS Aragón)
-
Marta Teresa Fernández
(OPE IIS Aragón)
CNRS
The main public research organization in France.
Role:
It is responsible for designing biofunctionalized nanoparticles and developing analytical methods that should allow selective detection of Borrelia bacteria.
URL:
https://www.cnrs.fr/-
Dr. Christophe Peycheran
(IPREM – CNRS Délégation Aquitaine)
-
Dr. Joachim Allouche
(IPREM- CNRS Délégation Aquitaine)
-
Dra. Hélène Tabouret
(IPREM- CNRS Délégation Aquitaine)
-
Marie ROUBY
(CNRS Délégation Aquitaine)
Hôpitaux de Lannemezan
Public reference hospital for Lyme disease.
Role:
CH Lannemezan will provide patient and control samples, additional clinical information, and evaluate the performance of the diagnostic method.
URL:
https://www.ch-lannemezan.fr-
Dr. Raouf Ghozzi
(CH Lannemezan)
-
Hassan El Mazani
(CH Lannemezan)
Associated Entities
Institutions associated with the project that will receive training on the developed diagnostic technique.
